Nodular pulmonary amyloidosis diagnosed by ultrasound-guided percutaneous needle biopsy
- PMID: 38745726
- PMCID: PMC11091706
- DOI: 10.1016/j.rmcr.2024.102025
Nodular pulmonary amyloidosis diagnosed by ultrasound-guided percutaneous needle biopsy
Abstract
Pulmonary amyloidosis is characterized by extracellular deposition of fibrous protein called amyloid in the lungs and has three subtypes: nodular, diffuse, and tracheobronchial amyloidosis. Pulmonary nodular amyloidosis can mimic other lung diseases including infectious diseases, metastatic lung tumors, sarcoidosis, and pulmonary hyalinizing granuloma. A biopsy of the lesion is essential for a definitive diagnosis. Herein, we report the case of a 66-year-old man who presented for shortness of breath on exertion and was diagnosed with nodular pulmonary amyloidosis on ultrasound-guided percutaneous needle biopsy. A chest X-ray and computed tomography (CT) revealed bilateral slowly growing multiple calcified pulmonary nodules and cavities. Malignancy was suspected based on 18F-fluoro-deoxyglucose (18F-FDG) positron emission tomography/CT (PET/CT) images. An ultrasound-guided percutaneous needle biopsy was performed, and histopathologic examination of the lesion confirmed nodular pulmonary amyloidosis. This case highlights the importance of considering nodular pulmonary amyloidosis in the differential diagnosis of pulmonary nodules with increased uptake of 18F-FDG on PET/CT and the utility of ultrasound-guided needle biopsy in the definitive diagnosis.
Keywords: 18F-fluoro-deoxyglucose (18F-FDG) positron emission tomography; Nodular pulmonary amyloidosis; Systemic AL amyloidosis; Ultrasound-guided percutaneous needle biopsy.
© 2024 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. No conflicts of interest.
Figures




References
Publication types
LinkOut - more resources
Full Text Sources